Dextran 70 6% in 5% Dextrose Disease Interactions
There are 4 disease interactions with Dextran 70 6% in 5% Dextrose (dextran, high molecular weight).
Dextran (applies to Dextran 70 6% in 5% Dextrose) cardiac failure
Major Potential Hazard, Moderate plausibility. Applicable conditions: Heart Disease
Low molecular weight and high molecular weight dextran is contraindicated in patients with marked cardiac decompensation.
Dextran (applies to Dextran 70 6% in 5% Dextrose) hemostatic defects
Major Potential Hazard, Moderate plausibility. Applicable conditions: Bleeding Associated with Coagulation Defect, Thrombocytopenia
The use of dextran is contraindicated in patients with marked hemostatic defects of all types (thrombocytopenia, hypofibrinogenemia, etc.) including those caused by drugs such as heparin, warfarin, etc.
Dextran (applies to Dextran 70 6% in 5% Dextrose) renal impairment
Major Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Low molecular and high molecular weight dextran are contraindicated in patients with renal disease with severe oliguria or anuria.
Dextran (applies to Dextran 70 6% in 5% Dextrose) bleeding
Moderate Potential Hazard, Moderate plausibility.
Caution should be employed when using dextran (low and high molecular weight) in patients with active hemorrhage as the resulting increase in perfusion pressure and improved microcirculatory flow may result in additional blood loss.
Switch to professional interaction data
Dextran 70 6% in 5% Dextrose drug interactions
There are 32 drug interactions with Dextran 70 6% in 5% Dextrose (dextran, high molecular weight).
Report options
More about Dextran 70 6% in 5% Dextrose (dextran, high molecular weight)
- Dextran 70 6% in 5% Dextrose consumer information
- Check interactions
- Compare alternatives
- Side effects
- Drug class: plasma expanders
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Zoladex
Zoladex (goserelin) is used to treat endometriosis and breast cancer in women and prostate cancer ...
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Promacta
Promacta is used to prevent bleeding episodes in patients with chronic immune (idiopathic) ...
Aminocaproic acid
Aminocaproic acid systemic is used for fibrinolytic bleeding
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.